Questions About Cancer? 1-800-4-CANCER

Cancer Drug Information

  • Posted: 10/05/2006
  • Updated: 05/03/2012

Tamoxifen Citrate

listen 1  (tuh-MOK-sih-FEN SIH-trayt)

This page contains brief information about tamoxifen citrate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Nolvadex
Novaldex
FDA Approved: Yes

Use in Cancer

Tamoxifen citrate is approved to treat:

Tamoxifen citrate is also approved to prevent:

  • Breast cancer in women who are at high risk for the disease.

Tamoxifen citrate is also being studied in the treatment of other types of cancer.

More About Tamoxifen Citrate

Definition from the NCI Drug Dictionary 2 - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Tamoxifen Citrate 3 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Hormone Therapy for Breast Cancer 4 - Information about the use of this drug to prevent and treat cancer.

Commonly Prescribed Antidepressant May Reduce Effectiveness of Tamoxifen in Women with Breast Cancer 5 - Information from NCI about this drug.

Targeted Cancer Therapies 6 - Information about the use of this drug to treat cancer.

Research Results

Clinical Trial Results: Exemestane Following Tamoxifen Reduces Breast Cancer Recurrences and Prolongs Survival 7 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Study Confirms Letrozole Prevents More Breast Cancer Recurrences Than Tamoxifen 8 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Long-Term Data from 20 Trials Confirm Tamoxifen’s Long-Lasting Benefit 9 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Tool Weighs Benefits, Risks of Raloxifene or Tamoxifen to Prevent Breast Cancer 10 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Five Years of Tamoxifen Continues to Benefit Women 15 Years after Treatment 11 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Some Older Women Can Forgo Radiation after Breast Cancer Surgery 12 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Zoledronic Acid Improves Early Breast Cancer Treatment 13 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole, Tamoxifen, and Bone Loss on the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial 14 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Studies Affirm Tamoxifen's Long-Term Preventive Benefit 15 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole After Tamoxifen Better for Early Breast Cancer than Tamoxifen Alone 16 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Advanced Breast Cancer Patients Benefit More from Aromatase Inhibitors than Tamoxifen 17 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole May Be Better than Tamoxifen at Shrinking Large Breast Tumors Before Surgery 18 - Important clinical trial results for this drug, background information, and how the trial was done.

Results of the Study of Tamoxifen and Raloxifene (STAR) Released: Osteoporosis Drug Raloxifene Shown to be as Effective as Tamoxifen in Preventing Invasive Breast Cancer 19 - Information from the NCI Press Office about this drug.

Benefits and Risks of Tamoxifen are Similar in African American and White Women 20 - Information from the NCI Press Office about this drug.

The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers 21 - Information from the NCI Press Office about this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Tamoxifen Citrate 22 - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top



Glossary Terms

breast cancer (brest KAN-ser)
Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.
cancer (KAN-ser)
A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.
prevention (pree-VEN-shun)
In medicine, action taken to decrease the chance of getting a disease or condition. For example, cancer prevention includes avoiding risk factors (such as smoking, obesity, lack of exercise, and radiation exposure) and increasing protective factors (such as getting regular physical activity, staying at a healthy weight, and having a healthy diet).

Table of Links

1http://www.cancer.gov/PublishedContent/Media/CDR/Media/718614.mp3
2http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=42901
3http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682414.html
4http://cancer.gov/cancertopics/factsheet/Therapy/hormone-therapy-breast
5http://www.cancer.gov/cancertopics/treatment/breast/tamoxifen-and-SSRIs0510
6http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted
7http://www.cancer.gov/clinicaltrials/results/summary/2012/exemestane0212
8http://www.cancer.gov/clinicaltrials/results/summary/2011/BIG1981211
9http://www.cancer.gov/clinicaltrials/results/summary/2011/tamoxifen1111
10http://www.cancer.gov/clinicaltrials/results/summary/2011/prevention-benefit-to
ol0611
11http://www.cancer.gov/clinicaltrials/results/summary/2011/tamoxifen0611
12http://www.cancer.gov/clinicaltrials/results/radiation-older-patients0610
13http://www.cancer.gov/clinicaltrials/results/zoledronic-acid0608
14http://www.cancer.gov/clinicaltrials/results/ATAC-bone0308
15http://www.cancer.gov/clinicaltrials/results/tamoxifen-update0307
16http://www.cancer.gov/clinicaltrials/results/anastrozole0805
17http://cancer.gov/clinicaltrials/results/aromatase-inhibitors1006
18http://www.cancer.gov/clinicaltrials/results/neoadjuvant-anastrozole0805
19http://www.cancer.gov/newscenter/pressreleases/STARresultsApr172006
20http://www.cancer.gov/newscenter/pressreleases/ContralateralBreast
21http://www.cancer.gov/newscenter/STARresultsQandA
22http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42901&idtype=1
23http://www.cancer.gov/cancertopics/druginfo/alphalist
24http://www.cancer.gov/cancertopics/druginfo/drug-page-index
25http://www.cancer.gov/clinicaltrials/learningabout/approval-process-for-cancer-
drugs
26http://www.cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access